Market open · Oct 1, 11:50 am ET · After hours $365.94 0.00%
Open$367.94
Prev close$365.94
Day range$361.63 – $371.02
Volume106.7K
Market cap$41.19B
P/E (TTM)64.1
Dividend yield–
ONC Stock News
Headlines matching BeiGene or the ONC ticker, most recent first.
UBS Group: Most Chinese biotech firms exceeded sales expectations in the first half; global R&D catalysts will be key in the second half. Top pick: BeiGene (ONC.US)Zhitong Finance · 7 Sep 2026
CLSA: Fundamentals of China's biotechnology sector remain solid; top picks are BeiGene (06160), Innovent Bio (01801), and WeLiShengBo (09887).Zhitong Finance · 7 Sep 2026
The Capital Group increased its holdings in BeiGene (06160.HK) by 1.9494 million H shares, valued at approximately USD 699 million.Market news · 28 Sep 2026
Barclays Maintains BeiGene(ONC.US) With Buy Rating, Raises Target Price to $415Market news · 10 Sep 2026
BeiGene (688235): Strong sales of its flagship product and continued expansion of its pipeline.CITIC Securities · 9 Aug 2026
Record of Investor Relations Activities of BeiGene, Ltd. (August 2026)SZSI · 7 Aug 2026
BeiGene (688235): Strong U.S. Market Performance and Efficient Advancement of Solid Tumor R&DChina Post Securities · 7 Aug 2026
A Quick Look at Today's Ratings for BeiGene(ONC.US), With a Forecast Between $400 to $466Market news · 7 Aug 2026
No comments yet — be the first to weigh in on ONC.